Literature DB >> 7615836

Experimental liver cirrhosis induced by alcohol and iron.

H Tsukamoto1, W Horne, S Kamimura, O Niemelä, S Parkkila, S Ylä-Herttuala, G M Brittenham.   

Abstract

To determine if alcoholic liver fibrogenesis is exacerbated by dietary iron supplementation, carbonyl iron (0.25% wt/vol) was intragastrically infused with or without ethanol to rats for 16 wk. Carbonyl iron had no effect on blood alcohol concentration, hepatic biochemical measurements, or liver histology in control animals. In both ethanol-fed and control rats, the supplementation produced a two- to threefold increase in the mean hepatic non-heme iron concentration but it remained within or near the range found in normal human subjects. As previously shown, the concentrations of liver malondialdehyde (MDA), liver 4-hydroxynonenal (4HNE), and serum aminotransferases (ALT, AST) were significantly elevated by ethanol infusion alone. The addition of iron supplementation to ethanol resulted in a further twofold increment in mean MDA, 4HNE, ALT, and AST. On histological examination, focal fibrosis was found < 30% of the rats fed ethanol alone. In animals given both ethanol and iron, fibrosis was present in all, with a diffuse central-central bridging pattern in 60%, and two animals (17%) developed micronodular cirrhosis. The iron-potentiated alcoholic liver fibrogenesis was closely associated with intense and diffuse immunostaining for MDA and 4HNE adduct epitopes in the livers. Furthermore, in these animals, accentuated increases in procollagen alpha 1(I) and TGF beta 1 mRNA levels were found in both liver tissues and freshly isolated hepatic stellate cells, perisinusoidal cells believed to be a major source of extracellular matrices in liver fibrosis. The dietary iron supplementation to intragastric ethanol infusion exacerbates hepatocyte damage, promotes liver fibrogenesis, and produces evident cirrhosis in some animals. These results provide evidence for a critical role of iron and iron-catalyzed oxidant stress in progression of alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615836      PMCID: PMC185237          DOI: 10.1172/JCI118077

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  STORAGE IRON IN MAN.

Authors:  A WEINFELD
Journal:  Acta Med Scand Suppl       Date:  1964

2.  The relation of portal cirrhosis to hemochromatosis and to diabetes mellitus.

Authors:  E T BELL
Journal:  Diabetes       Date:  1955 Nov-Dec       Impact factor: 9.461

3.  A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues.

Authors:  I S Jamall; V N Finelli; S S Que Hee
Journal:  Anal Biochem       Date:  1981-03-15       Impact factor: 3.365

4.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.

Authors:  O W Griffith
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

5.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

Authors:  M Mihara; M Uchiyama
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

6.  Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation.

Authors:  O Niemelä; S Parkkila; S Ylä-Herttuala; C Halsted; J L Witztum; A Lanca; Y Israel
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

7.  Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes.

Authors:  H Esterbauer; K H Cheeseman; M U Dianzani; G Poli; T F Slater
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

8.  Changes in cytochromes P-450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury.

Authors:  A A Nanji; S Zhao; R G Lamb; A J Dannenberg; S M Sadrzadeh; D J Waxman
Journal:  Alcohol Clin Exp Res       Date:  1994-08       Impact factor: 3.455

9.  Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis.

Authors:  M Morimoto; A L Hagbjörk; A A Nanji; M Ingelman-Sundberg; K O Lindros; P C Fu; E Albano; S W French
Journal:  Alcohol       Date:  1993 Nov-Dec       Impact factor: 2.405

10.  Regulation of interleukin 8 gene expression by oxidant stress.

Authors:  L E DeForge; A M Preston; E Takeuchi; J Kenney; L A Boxer; D G Remick
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

View more
  111 in total

1.  Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation.

Authors:  Rajat Singh; Yongjun Wang; Jörn M Schattenberg; Youqing Xiang; Mark J Czaja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

2.  Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells.

Authors:  Komal Ramani; Maria Lauda Tomasi
Journal:  Hepatology       Date:  2012-04-23       Impact factor: 17.425

Review 3.  Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

Authors:  Tung Ming Leung; Yongke Lu
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

4.  The global burden of iron overload.

Authors:  Marnie J Wood; Richard Skoien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2009-07-29       Impact factor: 6.047

5.  Role of A-Kinase Anchoring Protein Phosphorylation in Alcohol-Induced Liver Injury and Hepatic Stellate Cell Activation.

Authors:  Komal Ramani; Maria Lauda Tomasi; Joshua Berlind; Nirmala Mavila; Zhaoli Sun
Journal:  Am J Pathol       Date:  2018-01-02       Impact factor: 4.307

6.  Fatty liver in H63D homozygotes with hyperferritinemia.

Authors:  Giada Sebastiani; Daniel F Wallace; Susan E Davies; Vasu Kulhalli; Ann P Walker; James S Dooley
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.

Authors:  Anping Chen
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

Authors:  Anping Chen; Li Zhang; Jianye Xu; Jun Tang
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

10.  Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis.

Authors:  Güldeniz Karadeniz; Serefden Acikgoz; Ishak Ozel Tekin; Oge Tascýlar; Banu Dogan Gun; Mustafa Cömert
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.